Evidence map›Paper›PMID 42022799›Full record

ArticleFrontiers in cellular and infection microbiology2026

Essential oil-based hydrogels for oral candidiasis: preliminary formulation development, antifungal efficacy, and computational analysis via Monte Carlo simulation.

Adeola Tawakalitu Kola-Mustapha, Favour Temidayo John, Ronke Hadiyat Bello, Oluwakorede Joshua Adedeji, Yusuf Oluwagbenga Ghazali, Fahd Adebola Khalid-Salako, George Oche Ambrose

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Adeola Tawakalitu Kola-MustaphaCollege of Pharmacy, Alfaisal University, Riyadh, Saudi Arabia.
Favour Temidayo JohnFaculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria.
Ronke Hadiyat BelloFaculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria.
Oluwakorede Joshua AdedejiFaculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria.
Yusuf Oluwagbenga GhazaliFaculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria.
Fahd Adebola Khalid-SalakoSabanci Universitesi, Istanbul, Türkiye.
George Oche AmbroseUniversity of Ilorin Teaching Hospital, Ilorin, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to evaluate the inhibitory activity of the essential oils (EOs) of Method: The antifungal activity of both essential oils singly and in combination was performed using macro and checkerboard dilution against a standard Results and Discussion: Both EOs exhibited MIC of 100 μL/mL and MFC of 100 to 200 μL/mL depending on isolate; and a ΣFIC value of 0.75 indicating an additive outcome among 71% of the isolates. The EOs were formulated in hydrogels, the efficacies of which were tested using agar well diffusion method. The prepared hydrogels containing 3% w/w EOs in the ratio of 2:1 exhibited the best antifungal activity with desirably physicochemical and stability properties. Monte Carlo simulations (n = 10,000) further quantified the antifungal efficacy, revealing significantly enhanced inhibition arising from a synergistic effect of both EOs in combination. These findings highlight the promise of natural compounds as antifungal agents targeting critical fungal biosynthetic pathways and provide a basis for formulating EOs in hydrogels, potentially for the management of oral candidiasis.

Indexed as

Antifungal AgentsCandida albicansCandidiasis, OralHydrogelsOils, VolatileCymbopogonHumansMicrobial Sensitivity TestsMonte Carlo MethodSyzygiumAntifungal AgentsHydrogelsOils, VolatileantifungalCymbopogon flexuosushydrogelsoral candidiasisSyzygium aromaticum

Identifiers

PMID42022799
PMCPMC13096092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.